Immunotherapy for the Treatment of Urothelial Carcinoma
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2016-07-25 / J Urol 2017 01;197(1):14-22Lung adenocarcinoma may be a more susceptive subtype to a dendritic cell-based cancer vaccine than other subtypes of non-small cell lung cancers: a multicenter retrospective analysis
/in Dendritic Cells, International Publications, NSCLC /von 2016-07-22 / Cancer Immunol. Immunother. 2016 09;65(9):1099-111Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-07-21 / Onco Targets Ther 2016;9:4441-51PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-07-19 / Clin. Cancer Res. 2017 Jan;23(2):399-406Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2016-07-18 / Case Rep Med 2016;2016:9639585Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2016-07-12 / Cytotherapy 2016 09;18(9):1178-86A Perspective of Immunotherapy for Prostate Cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2016-07-07 / Cancers (Basel) 2016 Jul;8(7)PD-1 blockade enhances the vaccination-induced immune response in glioma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2016-07-07 / JCI Insight 2016 Jul;1(10)Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER/HER2 early breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2016-07-01 / Oncoimmunology 2017;6(9):e1207032
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution